ResMed EBITDA 2010-2025 | RMD
ResMed annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- ResMed EBITDA for the quarter ending March 31, 2025 was $0.478B, a 11.4% increase year-over-year.
- ResMed EBITDA for the twelve months ending March 31, 2025 was $1.828B, a 27.8% increase year-over-year.
- ResMed 2024 annual EBITDA was $1.536B, a 15.55% increase from 2023.
- ResMed 2023 annual EBITDA was $1.329B, a 11.33% increase from 2022.
- ResMed 2022 annual EBITDA was $1.194B, a 9.03% increase from 2021.
| ResMed Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $1,536 |
| 2023 | $1,329 |
| 2022 | $1,194 |
| 2021 | $1,095 |
| 2020 | $991 |
| 2019 | $730 |
| 2018 | $662 |
| 2017 | $538 |
| 2016 | $516 |
| 2015 | $482 |
| 2014 | $479 |
| 2013 | $433 |
| 2012 | $380 |
| 2011 | $338 |
| 2010 | $302 |
| 2009 | $244 |
| ResMed Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $478 |
| 2024-12-31 | $473 |
| 2024-09-30 | $441 |
| 2024-06-30 | $436 |
| 2024-03-31 | $429 |
| 2023-12-31 | $328 |
| 2023-09-30 | $342 |
| 2023-06-30 | $330 |
| 2023-03-31 | $353 |
| 2022-12-31 | $326 |
| 2022-09-30 | $320 |
| 2022-06-30 | $300 |
| 2022-03-31 | $286 |
| 2021-12-31 | $298 |
| 2021-09-30 | $310 |
| 2021-06-30 | $287 |
| 2021-03-31 | $271 |
| 2020-12-31 | $270 |
| 2020-09-30 | $267 |
| 2020-06-30 | $269 |
| 2020-03-31 | $264 |
| 2019-12-31 | $243 |
| 2019-09-30 | $215 |
| 2019-06-30 | $164 |
| 2019-03-31 | $199 |
| 2018-12-31 | $193 |
| 2018-09-30 | $175 |
| 2018-06-30 | $179 |
| 2018-03-31 | $166 |
| 2017-12-31 | $175 |
| 2017-09-30 | $142 |
| 2017-06-30 | $156 |
| 2017-03-31 | $136 |
| 2016-12-31 | $125 |
| 2016-09-30 | $122 |
| 2016-06-30 | $146 |
| 2016-03-31 | $124 |
| 2015-12-31 | $129 |
| 2015-09-30 | $116 |
| 2015-06-30 | $117 |
| 2015-03-31 | $124 |
| 2014-12-31 | $128 |
| 2014-09-30 | $113 |
| 2014-06-30 | $118 |
| 2014-03-31 | $122 |
| 2013-12-31 | $124 |
| 2013-09-30 | $115 |
| 2013-06-30 | $106 |
| 2013-03-31 | $117 |
| 2012-12-31 | $111 |
| 2012-09-30 | $99 |
| 2012-06-30 | $112 |
| 2012-03-31 | $97 |
| 2011-12-31 | $90 |
| 2011-09-30 | $81 |
| 2011-06-30 | $86 |
| 2011-03-31 | $82 |
| 2010-12-31 | $87 |
| 2010-09-30 | $82 |
| 2010-06-30 | $84 |
| 2010-03-31 | $77 |
| 2009-12-31 | $74 |
| 2009-09-30 | $67 |
| 2009-06-30 | $73 |
| 2009-03-31 | $65 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $37.196B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.381B | 27.82 |
| Boston Scientific (BSX) | United States | $149.868B | 37.52 |
| Stryker (SYK) | United States | $143.347B | 29.97 |
| EssilorLuxottica (ESLOY) | France | $128.152B | 0.00 |
| Medtronic (MDT) | Ireland | $110.735B | 15.70 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.273B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.811B | 26.69 |
| Agilent Technologies (A) | United States | $32.827B | 21.40 |
| GE HealthCare Technologies (GEHC) | United States | $32.638B | 15.50 |
| Terumo (TRUMY) | Japan | $26.398B | 34.29 |
| Koninklijke Philips (PHG) | Netherlands | $21.463B | 15.06 |
| Insulet (PODD) | United States | $21.334B | 83.74 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.048B | 11.59 |
| Baxter (BAX) | United States | $15.390B | 11.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.627B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.442B | 22.42 |
| Lantheus Holdings (LNTH) | United States | $5.479B | 13.82 |
| Prestige Consumer Healthcare (PBH) | United States | $4.123B | 18.42 |
| Perrigo (PRGO) | Ireland | $3.643B | 9.23 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.415B | 15.55 |
| Envista Holdings (NVST) | United States | $3.202B | 26.61 |
| ICU Medical (ICUI) | United States | $3.144B | 23.18 |
| GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
| QuidelOrtho (QDEL) | United States | $1.896B | 13.04 |
| LeMaitre Vascular (LMAT) | United States | $1.848B | 41.30 |
| AtriCure (ATRC) | United States | $1.554B | 0.00 |
| Acuren (TIC) | United States | $1.324B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.132B | 11.49 |
| Neogen (NEOG) | United States | $1.072B | 13.72 |
| Green Thumb Industries (GTBIF) | United States | $1.042B | 23.43 |
| BioLife Solutions (BLFS) | United States | $1.008B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.968B | 12.37 |
| InMode (INMD) | Israel | $0.839B | 8.46 |
| Kestra Medical Technologies (KMTS) | United States | $0.772B | 0.00 |
| CeriBell (CBLL) | United States | $0.647B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Owens & Minor (OMI) | United States | $0.567B | 4.71 |
| Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.525B | 0.00 |
| Valneva SE (VALN) | France | $0.478B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.377B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.362B | 0.00 |
| SNDL (SNDL) | Canada | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.319B | 11.74 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.288B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.262B | 22.07 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| ZimVie (ZIMV) | United States | $0.245B | 11.13 |
| Sanara MedTech (SMTI) | United States | $0.242B | 0.00 |
| Quanterix (QTRX) | United States | $0.238B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.229B | 68.00 |
| Canopy Growth (CGC) | Canada | $0.228B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Biote (BTMD) | United States | $0.217B | 6.09 |
| Cresco Labs (CRLBF) | United States | $0.212B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
| Brainsway (BWAY) | Israel | $0.206B | 54.55 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.174B | 14.19 |
| Verano Holdings (VRNOF) | United States | $0.174B | 0.00 |
| Organigram Global (OGI) | Canada | $0.173B | 0.00 |
| Exagen (XGN) | United States | $0.154B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 0.00 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Veru (VERU) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.34 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| MacroGenics (MGNX) | United States | $0.083B | 0.00 |
| Agape ATP (ATPC) | $0.079B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| Apyx Medical (APYX) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| ImmuCell (ICCC) | United States | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Nephros (NEPH) | United States | $0.053B | 71.43 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 12.98 |
| Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |